OMAB(OMAB)
OMAB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $17.40B | $19.89B | $22.37B | $22.99B | $23.66B |
| Low | $16.67B | $18.40B | $20.69B | $21.27B | $21.89B |
| High | $18.25B | $20.05B | $24.90B | $25.59B | $26.34B |
| EBITDA Avg | $12.17B | $13.91B | $15.65B | $16.08B | $16.55B |
| Low | $11.66B | $12.87B | $14.47B | $14.88B | $15.31B |
| High | $12.76B | $14.03B | $17.42B | $17.90B | $18.42B |
| EBIT Avg | $11.24B | $12.84B | $14.44B | $14.84B | $15.27B |
| Low | $10.76B | $11.88B | $13.36B | $13.73B | $14.13B |
| High | $11.78B | $12.95B | $16.07B | $16.52B | $17.00B |
| Net Income Avg | $6.45B | $7.40B | $8.47B | $9.91B | $11.41B |
| Low | $6.13B | $6.52B | $7.65B | $8.95B | $10.30B |
| High | $6.63B | $7.92B | $9.72B | $11.37B | $13.08B |
| EPS Avg | $133.63 | $153.32 | $175.55 | $205.32 | $236.28 |
| Low | $126.90 | $135.14 | $158.48 | $185.36 | $213.31 |
| High | $137.28 | $164.01 | $201.39 | $235.55 | $271.06 |
| Analysts (Rev / EPS) | 5 / 3 | 5 / 3 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.39B | $4.39B | $4.22B | $3.82B | $3.83B | $3.83B | $3.83B | $3.83B |
| Low | $4.18B | $4.04B | $3.89B | $3.53B | $3.53B | $3.53B | $3.53B | $3.53B |
| High | $4.60B | $5.03B | $4.83B | $4.38B | $4.38B | $4.39B | $4.39B | $4.39B |
| EBITDA Avg | $3.07B | $3.07B | $2.95B | $2.68B | $2.68B | $2.68B | $2.68B | $2.68B |
| Low | $2.92B | $2.83B | $2.72B | $2.47B | $2.47B | $2.47B | $2.47B | $2.47B |
| High | $3.22B | $3.52B | $3.38B | $3.06B | $3.07B | $3.07B | $3.07B | $3.07B |
| EBIT Avg | $2.83B | $2.83B | $2.72B | $2.47B | $2.47B | $2.47B | $2.47B | $2.47B |
| Low | $2.70B | $2.61B | $2.51B | $2.28B | $2.28B | $2.28B | $2.28B | $2.28B |
| High | $2.97B | $3.25B | $3.12B | $2.83B | $2.83B | $2.83B | $2.83B | $2.83B |
| Net Income Avg | $1.70B | $1.65B | $1.63B | $2.10B | $2.21B | $2.00B | $1.98B | $2.37B |
| Low | $1.63B | $1.48B | $1.47B | $1.89B | $1.99B | $1.80B | $1.78B | $2.13B |
| High | $1.77B | $1.97B | $1.94B | $2.50B | $2.63B | $2.38B | $2.36B | $2.82B |
| EPS Avg | $35.26 | $34.24 | $33.81 | $43.47 | $45.86 | $41.48 | $41.04 | $49.15 |
| Low | $33.86 | $30.76 | $30.37 | $39.05 | $41.20 | $37.26 | $36.87 | $44.15 |
| High | $36.67 | $40.73 | $40.21 | $51.71 | $54.55 | $49.34 | $48.81 | $58.46 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |